Life Sciences Innovative Manufacturing Fund
The question
To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what progress he has made on bringing globally mobile manufacturing investments to the UK via the Life Sciences Innovative Manufacturing Fund.
Answered by Kanishka Narayan
The up to £520m Life Sciences Innovative Manufacturing Fund was launched in 2024 to incentivise commercial-scale manufacturing of medicines and medical devices. The fund aims to drive economic growth and build UK health resilience. There have been four application rounds to date and we expect to announce the first set of grant winners in the coming month. In addition, we have recently invested £30 million in a new UK RNA Biofoundry, and we continue to work on our long-term partnerships with Moderna and BioNTech, which will grow the UK’s manufacturing and R&D capabilities for the benefit of UK patients.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →